These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 3552202)

  • 21. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
    Oyaizu T; Arita S; Hatano T; Tsubura A
    J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibitory effect of tamoxifen on the breast cancer risk induced by exogenous estrogen in rat].
    Zeng X; Yao Z
    Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):176-9. PubMed ID: 9387675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Establishment of an estrogen receptor positive 3'-methyl-4-dimethylaminoazobenzene induced hepatoma cell line of rat and investigation of hormonal therapy].
    Kameda H
    Hokkaido Igaku Zasshi; 1996 Nov; 71(6):711-26. PubMed ID: 8996840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
    Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL;
    J Clin Oncol; 2007 May; 25(15):2006-11. PubMed ID: 17452676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
    Morimoto T; Yamamoto H; Komaki K; Konishi N; Tanaka T; Yamakawa T; Mori T; Sasa M; Monden Y
    Tokushima J Exp Med; 1990 Dec; 37(3-4):59-68. PubMed ID: 2128782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen.
    Bhattacharyya N; Ramsammy R; Eatman E; Hollis VW; Anderson WA
    J Submicrosc Cytol Pathol; 1994 Apr; 26(2):147-62. PubMed ID: 8019941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
    Yu KD; Liu GY; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Breast; 2007 Jun; 16(3):307-15. PubMed ID: 17293115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short term treatment of tamoxifen and estradiol on estradiol and progesterone receptors in rabbit uterus.
    Bhargava S; Murugesan K; Vij U; Bharti A; Farooq A
    Indian J Exp Biol; 1993 Aug; 31(8):673-6. PubMed ID: 8270280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative relationships between cytosol and nuclear estrogen and progesterone receptors in the R3327 prostatic carcinoma of rats treated with diethylstilbestrol.
    Mobbs BG; Johnson IE
    Prostate; 1986; 8(3):255-64. PubMed ID: 3703745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo occupancy of female rat brain estrogen receptors by 17beta-estradiol and tamoxifen.
    Pareto D; Alvarado M; Hanrahan SM; Biegon A
    Neuroimage; 2004 Nov; 23(3):1161-7. PubMed ID: 15528115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E; Borgna JL; Rochefort H
    Cancer Res; 1982 Jan; 42(1):317-23. PubMed ID: 7053859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of cytosolic and nuclear estrogen and progesterone receptor in benign, untreated, and treated malignant human prostatic tissue by radioligand binding and enzyme-immunoassays.
    Mobbs BG; Johnson IE; Liu Y
    Prostate; 1990; 16(3):235-44. PubMed ID: 1691841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rat uterine growth and induction of progesterone receptor without estrogen receptor translocation.
    Jordan VC; Tate AC; Lyman SD; Gosden B; Wolf MF; Bain RR; Welshons WV
    Endocrinology; 1985 May; 116(5):1845-57. PubMed ID: 3987619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies.
    Thorpe SM; Lykkesfeldt AE; Vinterby A; Lonsdorfer M
    Cancer Res; 1986 Aug; 46(8 Suppl):4251s-4255s. PubMed ID: 3015386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental and clinical study on endocrine therapy of breast carcinoma, with special reference to the nuclear estrogen receptor].
    Kubouchi K
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1405-17. PubMed ID: 6521721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation.
    Brustein S; Fruchter R; Greene GL; Pertschuk LP
    Mod Pathol; 1989 Sep; 2(5):449-55. PubMed ID: 2682614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors.
    Chwalisz K; Hegele-Hartung C; Fritzemeier KH; Beier HM; Elger W
    Endocrinology; 1991 Jul; 129(1):312-22. PubMed ID: 2055191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.